AstraZeneca PLCChange company Symbol lookupSelect an option...AZN AstraZeneca PLCEBIX Ebix IncFCRD First Eagle Alternative Capital BDC IncRWAY Runway Growth Finance CorpLITB LightInTheBox Holding Co LtdUEC Uranium Energy CorpNEE Nextera Energy IncMANT ManTech International CorpAMPE Ampio Pharmaceuticals IncMA Mastercard IncGo
Based in United Kingdom
AstraZeneca PLC (AstraZeneca) is a patient-focused biopharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines, primarily for the treatment of diseases. The Company is focused on three main therapy areas: Oncology; Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Its pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development. The Company has access to technologies, both internally and through its various collaborations. Its technologies include acoustic tube technology, advanced molecular imaging, cryo-electron microscopy (cryo-EM), functional genomics, multi-omics and AstraZeneca iLab. The Company’s acoustic tube technology helps it to handle and process millions of compounds for biological screening. Its AstraZeneca iLab is its prototype of an automated medicinal chemistry laboratory.
American Depositary Receipt (ADR) Fee
ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees
|
|
|
|
| |
Upcoming Events
Past Earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
| Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
|---|---|---|---|---|
| November 12, 2021 | Q3 2021 Earnings Release | $0.54 | $0.62 to $0.62 | $0.47 |
| July 29, 2021 | Q2 2021 Earnings Release | $0.45 | $0.43 to $0.43 | $0.48 |
| April 30, 2021 | Q1 2021 Earnings Release | $0.82 | $0.75 to $0.75 | $0.53 |
| February 11, 2021 | Q4 2020 Earnings Release | $0.535 | $0.68 to $0.68 | -- |
Past Dividends
| Ex-dividend date | Amount | Record date | Pay date |
|---|---|---|---|
| August 12, 2021 | $0.45 | August 13, 2021 | September 13, 2021 |
| February 25, 2021 | $0.95 | February 26, 2021 | March 29, 2021 |
Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.
, , , Copyright © 2022. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.